Cargando…
Fecal microbiota transplantation for patients on antibiotic treatment with C. difficile infection history (GRAFT): Study protocol for a phase II, randomized, double-blind, placebo-controlled trial to prevent recurrent C. difficile infections
Recurrent Clostridiodes difficile infections (rCDIs) are a burdensome problem. Patients with a history of CDI that are prescribed antibiotics are at a high risk for recurrence. Fecal microbiota transplantation (FMT) has been shown to be an effective treatment for rCDI, though there is little informa...
Autores principales: | Kates, Ashley E., Gaulke, Ilsa, De Wolfe, Travis, Zimbric, Michele, Haight, Kendra, Watson, Lauren, Suen, Garret, Kim, Kyungmann, Safdar, Nasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270544/ https://www.ncbi.nlm.nih.gov/pubmed/32518854 http://dx.doi.org/10.1016/j.conctc.2020.100576 |
Ejemplares similares
-
Clinical Characteristics and Fecal Microbiome in Recurrent Versus Nonrecurrent Clostridioides difficile Infection
por: Lanjewar, Swapnil, et al.
Publicado: (2021) -
Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
por: Zellmer, Caroline, et al.
Publicado: (2016) -
Changes to the Composition of the Gastrointestinal Microbiome after Probiotics for Clostridium difficile Infection in Adults
por: Eggers, Shoshannah, et al.
Publicado: (2017) -
2359. Prospective Feasibility Study for Novel Ultrasensitive Multiplexed Immunoassay for Clostridiodes difficile Toxins A and B
por: Watson, Lauren, et al.
Publicado: (2019) -
The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2022)